Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 2040 for “"egfr"”.
-
Der Einfluss der EGFR Expressionsdichte auf die EGFR Antikörper gerichteten Abwehrmechanismen
Der epidermale Wachstumsfaktor-Rezeptor (EGFR) ist eine wichtige Zielstruktur für EGFR-gerichtete Antikörper, wie Cetuximab oder Panitumumab, welche bereits erfolgreich für Antikörper-basierte Tumortherapien verwendet werden.In der vorliegenden Arbeit wurde eine Reihe von BHK-EGFR+ Zelllinien mit …
-
Methylation of Egfr By Arginine Methyltransferase Prmt1 Enhances Egfr Signaling and Cetuximab Resistance
… of epidermal growth factor receptor (EGFR) intracellular domain are well known regulators of EGFR functions whereas those of its extracellular domain remain relatively unexplored. Here, we report that methylation at R198 and R200 of EGFR extracellular domain by protein arginine …
-
NCOA6 REPRESSES PROSTATE CANCER THROUGH INHIBITING EGFR ENHANCER ACTIVITY TO PREVENT EGFR OVEREXPRESSION
… profiling and ChIPseq data revealed that EGFR is a direct target gene of NCOA6. Consistently, NCOA6 KO results in EGFR upregulation in both 22Rv1 human PCa cells and mouse prostate tumor cells. Mechanistically, NCOA6 is recruited by transcription factor NF-Y to a previously unknown EGFR …
-
Characterisation and regulation of the Egfr/Egfr ligand system in fish models for melanoma
… for a mutated epidermal growth factor receptor (Egfr) and is called xmrk for Xiphophorus melanoma receptor kinase. Xmrk constitutive activation mechanisms and subsequent signaling pathways have already been investigated and charaterized but it is still unknown if Egfr ligands may also play a role …
-
Functional Crosstalk Between EphB6 and EGFR
… interacts with two members of the ErbB family, EGFR and ErbB4, my research focused on investigating possible functional crosstalk between EphB6 and EGFR in two different cancer cell line models. I found that the EphB6-EGFR interaction occurs in cancer cells, is driven by the extracellular …
-
Functional Crosstalk Between EphB6 and EGFR
… interacts with two members of the ErbB family, EGFR and ErbB4, my research focused on investigating possible functional crosstalk between EphB6 and EGFR in two different cancer cell line models. I found that the EphB6-EGFR interaction occurs in cancer cells, is driven by the extracellular …
-
Regulation of EGFR Degradation by Ankyrin105
Growth factors can regulate a variety of cellular processes by activating receptors on the cell surface. Many of the receptors belong to the receptor tyrosine kinase family, including the platelet-derived growth factor receptor and the epidermal growth factor receptor and its related family …
-
EGFR signaling from the early endosome.
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is an integral component of proliferative signaling. When activated by a ligand at the plasma membrane, EGFR dimerizes with another ErbB family receptor, leading to kinase domain activation and transphosphorylation of …
-
Isolation of EGFR-containing early endosomes.
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase (RTK) that is an integral component of proliferative signaling. When activated by a ligand at the plasma membrane, EGFR undergoes clathrin-mediated endocytosis. This spatial regulation of the receptor is an important …
-
MET-EGFR Dimerisation in Lung Adenocarcinoma is Dependent on EGFR Mutations and Altered by MET Kinase Inhibition
… is extremely poor with few effective therapies. EGFR tyrosine kinase inhibitors (TKIs) have high response rates in patients with activating EGFR mutations and are now an established part of therapy in selected patients. Such advances herald a previously unprecedented enthusiasm for the …
-
Μηχανισμοί αντίστασης στην θεραπεία με EGFR αναστολείς σε μη-μικροκυτταρικό καρκίνο πνεύμονα που φέρει μετάλλαξη του EGFR
… στον καρκίνο του πνεύμονα είναι το μονοπάτι του EGFR κι η ανάπτυξη μορίων που στοχεύουν τον μεταλλαγμένο υποδοχέα έχει αυξήσει σημαντικά την επιβίωση των ασθενών. Ωστόσο η αποτυχία των EGFRαναστολέων ακόμα και μετά από μακροχρόνια ύφεση οδήγησε στην ανάγκη για διερεύνηση κυτταρικών μηχανισμών …
-
Mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
… with mutant epidermal growth factor receptor (EGFR) is currently treated with tyrosine kinase inhibitors (TKIs). TKIs have proven effective in improving survival until resistance is conferred, mostly by way of the exon 20, threonine 790 to methionine (T790M) point mutation in EGFR. The …
-
EGFR and Akt Signaling in Rhabdomyosarcoma Pathogenesis
… that decreased Epidermal Growth Factor Receptor (EGFR) activity, which regulates myoblast fusion programming in flies, suppresses PAX-FOXO1 (PF)-induced lethality. As EGFR is pharmacologically targetable, we demonstrate that EGFR inhibitors antagonize RMS in a ERMS-RD cell line, but that other RMS …
-
EGFR signaling regulates synaptic connectivity via Gurken
… system. Mutants in happyhour, a regulator of EGFR signaling, form ectopic Type II neuromuscular junctions. These ectopic innervations are due to inappropriate target selection. I demonstrate that EGFR signaling is necessary and sufficient to inhibit synaptic target selection by these …
-
ERO1α Promotes Tumorigenesis in EGFR Driven NSCLC
Non-Small Cell Lung Cancer (NSCLC) is a pulmonary malignancy most commonly associated with smoking, or exposure to asbestos or Radon. Approximately, 1.6 Million deaths occur each year due to lung cancer. Lung Cancer is categorized by two main types, Small Cell Lung Cancer (SCLC) and NSCLC. NSCLC …
-
Igfbp2 Potentiates Egfr-Stat3 Signaling In Glioma
… overexpression lead to aberrant activation of EGFR, which subsequently activates STAT3 signaling. Furthermore, we demonstrate that IGFBP2 augments the nuclear accumulation of EGFR to potentiate STAT3 transactivation activities, via activation of the nuclear EGFR signaling pathway. Nuclear …
-
Charakterisierung rekombinanter IgA-Antikörper gegen den EGFR
… der Rezeptor des epidermalen Wachstumsfaktors (EGFR) als geeignete Zielstruktur. Endogen exprimiert erfüllt er wichtige physiologische Funktionen bei der Entwicklung und Aufrechterhaltung der Epithelien. Die Überexpression des EGFR führt zu einem konstitutiven Anschalten von karzinomfördernden …
-
Rekrutierung myeloischer Zellen durch EGFR-gerichtete Antikörper
… gegen den epidermalen Wachstumsfaktorrezeptor (EGFR) gerichtete Antikörper für die Behandlung epithelialer Karzinome zugelassen. Während Cetuximab und Necitumumab zum Immunglobulin G (IgG)-Isotyp 1 gehören, ist Panitumumab ein IgG2-Antikörper. Nur von IgG1-Antikörpern ist man der Auffassung, …
-
Primäre und sekundäre Resistenzmechanismen der EGFR Blockade
… den Arbeiten beispielhaft an Amphiregulin oder EGFRvIII Expression gezeigt, in der Interpretation erschweren. Präklinische Modelle, die die Erkrankungssituation 1:1 widerspiegeln, gibt es nicht. Ein präklinisches Modell, dass nah am Ausgangstumor bleibt, ist das PDX Modell. Es konnte gezeigt …
Page 1 of 102